Institutional Ownership
Iovance Biotherapeutics Inc
CUSIP 462260100COMIOVAQ1 2026
13D / 13G Filings
46
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
15.8%
Max % of class reported
Institutional Holders
276
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
46 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | State Street Corporation | 13G | 5.1% | 20.16M | SEC |
| 2 | Jul 29, 2025 | The Vanguard Group | 13G/A | 7.5% | 25.08M | SEC |
| 3 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 6.4% | 21.31M | SEC |
| 4 | May 15, 2025 | Perceptive Advisors LLC | 13G/A | 3.8% | 12.81M | SEC |
| 5 | Feb 14, 2025 | Perceptive Advisors LLC | 13G/A | 7.3% | 22.11M | SEC |
| 6 | Nov 14, 2024 | Perceptive Advisors LLC | 13G/A | 8.8% | 26.62M | SEC |
| 7 | Oct 18, 2024 | State Street Corp | 13G/A | 4.4% | 13.20M | SEC |
| 8 | Mar 19, 2024 | Quogue Capital LLC | 13D/A | 11.6% | 30.00M | SEC |
| 9 | Mar 1, 2024 | Perceptive Advisors LLC | 13G | 6.9% | 19.22M | SEC |
| 10 | Feb 14, 2024 | Perceptive Advisors LLC | 13G/A | 4.7% | 11.98M | SEC |
36 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Iovance Biotherapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 31.08M | $109.09M |
| 2 | Mhr Fund Management LLC | 28.97M | $101.67M |
| 3 | State Street Corp | 17.45M | $61.24M |
| 4 | Two Sigma Investments, LP | 13.69M | $48.04M |
| 5 | Millennium Management LLC | 9.41M | $33.04M |
| 6 | Goldman Sachs Group Inc | 8.76M | $30.75M |
| 7 | Geode Capital Management, LLC | 8.57M | $30.10M |
| 8 | Invenomic Capital Management LP | 8.50M | $29.82M |
| 9 | Bank Of America Corp /De/ | 8.49M | $29.80M |
| 10 | D. E. Shaw & Co., Inc. | 8.02M | $28.14M |